(Q44541384)

4 December 2017

title

Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years (English)

1 reference

4 December 2017

0 references

M Osoegawa

1

1 reference

4 December 2017

J Kira

2

1 reference

4 December 2017

T Fukazawa

3

1 reference

4 December 2017

K Fujihara

4

1 reference

4 December 2017

S Kikuchi

5

1 reference

4 December 2017

M Matsui

6

1 reference

4 December 2017

T Kohriyama

7

1 reference

4 December 2017

G Sobue

8

1 reference

4 December 2017

T Yamamura

9

1 reference

4 December 2017

Y Itoyama

10

1 reference

4 December 2017

T Saida

11

1 reference

4 December 2017

K Sakata

12

1 reference

4 December 2017

H Ochi

13

1 reference

4 December 2017

T Matsuoka

14

1 reference

4 December 2017

Research Committee of Neuroimmunological Diseases

15

1 reference

4 December 2017

language of work or name

1 reference

5 November 2008

1 reference

Multiple Sclerosis Journal

4 December 2017

published in

1 reference

4 December 2017

volume

15

1 reference

4 December 2017

issue

2

1 reference

4 December 2017

page(s)

159-173

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

4 December 2017

1 reference

Multiple sclerosis in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Clinical studies of multiple sclerosis in Japan. II. Are its clinical characteristics changing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Complexity and heterogeneity in demyelinating disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

The pattern of neurological illness in tropical Africa. Experience at Ibadan, Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Genetic epidemiology of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Multiple sclerosis and age at migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Role of return migration in the emergence of multiple sclerosis in the French West Indies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Nationwide survey of multiple sclerosis in Japan Clinical analysis of 1,084 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Epidemiology of idiopathic cardiomyopathy in Japan: results from a nationwide survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

The prevalence and clinical characteristics of MS in northern Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Sex ratio of multiple sclerosis in Canada: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Anticipation of age at onset in multiple sclerosis: a Sardinian cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Age at onset of multiple sclerosis may be influenced by place of residence during childhood rather than ancestry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

The clinical course of neuromyelitis optica (Devic's syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Analysis of HLA genes and haplotypes in Ainu (from Hokkaido, northern Japan) supports the premise that they descent from Upper Paleolithic populations of East Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Genetic origins of the Ainu inferred from combined DNA analyses of maternal and paternal lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

OSMS is NMO, but not MS: proven clinically and pathologically

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508098372

21 January 2018

Identifiers

DOI

10.1177/1352458508098372

1 reference

4 December 2017

1 reference